SION
Research Snapshot
Static fundamentals, valuation context, and investor signals for SIONNA THERAPEUTICS, INC. (SION).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-24.5%
ROIC, N/A FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 20.6x current ratio
Superinvestors
2
Top: Viking Global Investors (0.4%)
Strengths to research
- Debt/equity looks manageable at 0.0x.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 2 periods
Quarterly data: 8 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for SION.
Grade F
2
/ 100
Financial Charts
No financial data available for SION (annual).
2 superinvestors own SION
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 3,195,181 | $128M | 0.36% | 0.0% |
| Polen Capital Management Polen Capital Management | 26,775 | $1M | 0.01% | 0.0% |